[The effect of dimephosphon on exudative and proliferative processes]

Area of Science:

• Pharmacology
• Inflammation Research
• Drug Discovery

Background:

• Inflammation involves distinct exudative and proliferative phases.
• Non-steroidal anti-inflammatory drugs (NSAIDs) primarily target the proliferative phase.
• Histamine and serotonin are key mediators in inflammatory responses.

Purpose of the Study:

• To investigate the effects of dimephosphon on inflammatory models in rats.
• To evaluate dimephosphon's impact on histamine and serotonin levels during inflammation.
• To determine dimephosphon's mechanism of action compared to NSAIDs.

Main Methods:

• Utilized rat models of inflammation allowing separation of exudative and proliferative phases.
• Measured blood levels of histamine, serotonin, and their precursors in healthy and inflamed rats.
• Assessed dimephosphon's influence on the proliferative phase of inflammation.

Main Results:

• Dimephosphon did not inhibit the proliferative phase of inflammation, unlike NSAIDs.
• Dimephosphon demonstrated significant antihistamine activity.
• This antihistamine effect was attributed to the intensification of histaminopexy.

Conclusions:

• Dimephosphon possesses distinct anti-inflammatory properties, primarily through antihistamine action.
• The mechanism involves enhancing histaminopexy, reducing histamine availability.
• The identified antihistamine activity of dimephosphon warrants further investigation for therapeutic applications.